CARMANTE EXTRA: Open Payments
NPI 1356702997 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,807 in 18 payments from 7 companies in 2025. Trend: 2023 $516 · 2024 $439 · 2025 $2,807
Food & beverage: $1,057Honoraria: $980Travel & lodging: $770
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 9 | $2,262 |
| Deciphera Pharmaceuticals Inc. | 1 | $143 |
| Gilead Sciences, Inc. | 1 | $114 |
| E.R. Squibb & Sons, L.L.C. | 1 | $113 |
| Legend Biotech USA Inc. | 2 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| BeOne Medicines USA, Inc. | 1 | $26 |
Products named: CABOMETYX, QINLOCK, OPDIVO, CARVYKTI, PLUVICTO, TEVIMBRA.
Industry payments across FL — which companies pay providers there.
